{"id":17485,"date":"2022-08-29T04:39:06","date_gmt":"2022-08-29T04:39:06","guid":{"rendered":"http:\/\/www.pidsphil.org\/home\/?page_id=17485"},"modified":"2025-06-14T04:53:28","modified_gmt":"2025-06-14T04:53:28","slug":"journal-2018-vol-19-no-1-original-articles-6","status":"publish","type":"page","link":"https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/","title":{"rendered":"Journal 2018 Vol.19 No.1 Original Articles 6"},"content":{"rendered":"<p><strong><span class=\"journalTitle\"><span style=\"color: #800000;\">Journal 2018 Vol.19 No.1<\/span><\/span><\/strong><br \/>\n<strong>A Retrospective Study on the Outcome of Children with Extensively Drug-Resistant Gram-Negative Infection Treated with Colistin vs. Other Antimicrobials<\/strong><br \/>\n<em><strong>Carren Anne P. Batalla &#8211; Bocaling, M.D., Estrella B. Paje &#8211; Villar, M.D.<\/strong><\/em><br \/>\n<strong>Abstract<\/strong><br \/>\n<strong>Introduction: <\/strong>The increasing trend of extensively drug-resistant gram-negative infections led to the reconsideration of colistin as a valuable therapeutic option.<br \/>\n<strong>Objectives: <\/strong>To describe the clinical profile and treatment response of children with extensively drug resistant (XDR) Gram-negative infections given colistin versus other antimicrobials.<br \/>\n<strong>Methods: <\/strong>This retrospective descriptive study involved patients treated for XDR Gram-negative infections from January 2014 to June 2017 in a tertiary hospital in Metro Manila. Descriptive statistics were used to summarize clinical characteristics of subjects.<br \/>\nTreatment response to colistin versus other antimicrobial agents were compared in terms of success, failure, and toxicity. The Fisher-exact and Mann Whitney U tests were used to assess statistical differences between the colistin and non-colistin groups.<br \/>\n<strong>Results: <\/strong>Majority of patients with XDR Gramnegative infections had previous antibiotic exposure.<br \/>\nMore patients in the colistin group received TPN 43.2% vs 23.7% (p=0.035), had a longer hospital stay prior to the onset of XDR Gram-negative infection, 27 days vs. 15.5 days (p=0.001), and had a longer total hospital stay with a median of 52 days vs 30 days (p &lt; 0.001). Treatment success was significantly higher in the colistin group at 70.3%, as against 46.5% in the non-colistin group (p=0.014). There was no difference in the treatment duration of both groups. The colistin group had longer time to clinical response, with a mean of 6.27 (+ 3.57) days compared with those from the non-colistin group, with a mean of 4.36 (+ 1.77)(p=0.008). The colistin group had more fungal infections during the course of treatment (p=0.001).<br \/>\n<strong>Conclusion: <\/strong>Based on our institutional experience, colistin is considered relatively effective and safe in treating XDR Gram-negative infections in children.<br \/>\n<strong>Keywords: <\/strong>extensively drug-resistant gram-negative infection, healthcare associated infection, colistin<br \/>\n<strong><a href=\"https:\/\/doi.org\/10.56964\/pidspj20181901008\">https:\/\/doi.org\/10.56964\/pidspj20181901008<\/a><\/strong><br \/>\n<strong><a href=\"https:\/\/www.pidsphil.org\/home\/wp-content\/uploads\/2019\/02\/jo54_ja07.pdf\" target=\"_\" rel=\"noopener\">View Full Article in PDF format<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Journal 2018 Vol.19 No.1 A Retrospective Study on the Outcome of Children with Extensively Drug-Resistant Gram-Negative Infection Treated with Colistin vs. Other Antimicrobials Carren Anne P. Batalla &#8211; Bocaling, M.D., Estrella B. Paje &#8211; Villar, M.D. Abstract Introduction: The increasing trend of extensively drug-resistant gram-negative infections led to the reconsideration of colistin as a valuable  [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-17485","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Journal 2018 Vol.19 No.1 Original Articles 6 - Pediatric Infectious Disease Society of the Philippines<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Journal 2018 Vol.19 No.1 Original Articles 6 - Pediatric Infectious Disease Society of the Philippines\" \/>\n<meta property=\"og:description\" content=\"Journal 2018 Vol.19 No.1 A Retrospective Study on the Outcome of Children with Extensively Drug-Resistant Gram-Negative Infection Treated with Colistin vs. Other Antimicrobials Carren Anne P. Batalla &#8211; Bocaling, M.D., Estrella B. Paje &#8211; Villar, M.D. Abstract Introduction: The increasing trend of extensively drug-resistant gram-negative infections led to the reconsideration of colistin as a valuable [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Pediatric Infectious Disease Society of the Philippines\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-14T04:53:28+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2018-vol-19-no-1-original-articles-6\\\/\",\"url\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2018-vol-19-no-1-original-articles-6\\\/\",\"name\":\"Journal 2018 Vol.19 No.1 Original Articles 6 - Pediatric Infectious Disease Society of the Philippines\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/#website\"},\"datePublished\":\"2022-08-29T04:39:06+00:00\",\"dateModified\":\"2025-06-14T04:53:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2018-vol-19-no-1-original-articles-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2018-vol-19-no-1-original-articles-6\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/journal-2018-vol-19-no-1-original-articles-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Journal 2018 Vol.19 No.1 Original Articles 6\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/#website\",\"url\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/\",\"name\":\"Pediatric Infectious Disease Society of the Philippines\",\"description\":\"Pediatric Infectious Disease Society of the Philippines\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pidsphil.org\\\/home\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Journal 2018 Vol.19 No.1 Original Articles 6 - Pediatric Infectious Disease Society of the Philippines","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/","og_locale":"en_US","og_type":"article","og_title":"Journal 2018 Vol.19 No.1 Original Articles 6 - Pediatric Infectious Disease Society of the Philippines","og_description":"Journal 2018 Vol.19 No.1 A Retrospective Study on the Outcome of Children with Extensively Drug-Resistant Gram-Negative Infection Treated with Colistin vs. Other Antimicrobials Carren Anne P. Batalla &#8211; Bocaling, M.D., Estrella B. Paje &#8211; Villar, M.D. Abstract Introduction: The increasing trend of extensively drug-resistant gram-negative infections led to the reconsideration of colistin as a valuable [...]","og_url":"https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/","og_site_name":"Pediatric Infectious Disease Society of the Philippines","article_modified_time":"2025-06-14T04:53:28+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/","url":"https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/","name":"Journal 2018 Vol.19 No.1 Original Articles 6 - Pediatric Infectious Disease Society of the Philippines","isPartOf":{"@id":"https:\/\/www.pidsphil.org\/home\/#website"},"datePublished":"2022-08-29T04:39:06+00:00","dateModified":"2025-06-14T04:53:28+00:00","breadcrumb":{"@id":"https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.pidsphil.org\/home\/journal-2018-vol-19-no-1-original-articles-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pidsphil.org\/home\/"},{"@type":"ListItem","position":2,"name":"Journal 2018 Vol.19 No.1 Original Articles 6"}]},{"@type":"WebSite","@id":"https:\/\/www.pidsphil.org\/home\/#website","url":"https:\/\/www.pidsphil.org\/home\/","name":"Pediatric Infectious Disease Society of the Philippines","description":"Pediatric Infectious Disease Society of the Philippines","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pidsphil.org\/home\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/pages\/17485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/comments?post=17485"}],"version-history":[{"count":6,"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/pages\/17485\/revisions"}],"predecessor-version":[{"id":20053,"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/pages\/17485\/revisions\/20053"}],"wp:attachment":[{"href":"https:\/\/www.pidsphil.org\/home\/wp-json\/wp\/v2\/media?parent=17485"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}